Literature DB >> 9873876

Causes of death in Canadians with haemophilia 1980-1995. Association of Hemophilia Clinic Directors of Canada.

I R Walker1, J A Julian.   

Abstract

The life expectancy of individuals with haemophilia was close to that of the general population in the early 1980s. Since then, life expectancy has decreased, due to transfusion-transmitted virus infections. Deaths in individuals with haemophilia were investigated by analysing 2450 records from the Canadian Hemophilia Registry, for the years 1980-1995. Deaths were tabulated by age, year and cause, and compared with that of the Canadian male population by calculating standardized mortality ratios (SMRs). The median life expectancy at 1 year of age was calculated for various subpopulations and the impact of various population characteristics was assessed by survival regression modelling. There were 359 deaths and the annual number of deaths increased significantly after 1986. Risk factors were seropositivity to human immunodeficiency virus (relative risk 16.7, 95% CI 11.1-25.1), severe haemophilia (1.9, 1.3-2.7) and moderate haemophilia (1.8, 1.2-2.6). In HIV antibody negative individuals, the overall death rate was not increased (SMR 0.9, 95% CI 0.7-1.1) and only haemorrhage was significantly increased. In HIV antibody positive individuals, causes of death which were significantly increased were acquired immunodeficiency syndrome, liver failure, haemorrhage, lymphoma, liver cancer, nonspecific infections, and trauma or violence. Deaths due to the acquired immunodeficiency syndrome accounted for only 66% of the excess deaths in individuals who were HIV antibody positive. Life expectancy has markedly decreased since the onset of the HIV epidemic. The impact of HIV is underestimated by considering only deaths due to the acquired immunodeficiency syndrome; other HIV-linked causes need also to be considered.

Entities:  

Mesh:

Year:  1998        PMID: 9873876     DOI: 10.1046/j.1365-2516.1998.00179.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  12 in total

1.  Geographic location of commercial plasma donation clinics in the United States, 1980-1995.

Authors:  Robert C James; Cameron A Mustard
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

Review 2.  Haemophilia and cancer: a personal perspective.

Authors:  Massimo Franchini
Journal:  Blood Transfus       Date:  2012-07-04       Impact factor: 3.443

Review 3.  The haemophilia certification system in Canada.

Authors:  Davide Matino; Jerry Teitel; David Page; Arun Keepanasseril; Alfonso Iorio; Irwin Walker
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

Review 4.  Management of Hemophilia in Older Patients.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

5.  Austrian Hemophilia Registry: design, development and set of variables.

Authors:  Sylvia Reitter; Werner Streif; Thomas Schabetsberger; Florian Wozak; Hubert Hartl; Christoph Male; Wolfgang Muntean; Ingrid Pabinger
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

6.  Causes of death and mortality trends related to hemophilia in Brazil, 1999 to 2016.

Authors:  Augusto Hasiak Santo
Journal:  Hematol Transfus Cell Ther       Date:  2020-06-04

Review 7.  Comorbidities of cardiovascular disease and cancer in hemophilia patients.

Authors:  Jiaan-Der Wang
Journal:  Thromb J       Date:  2016-10-04

Review 8.  The management of hemophilia in elderly patients.

Authors:  Massimo Franchini; Annarita Tagliaferri; Pier Mannuccio Mannucci
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

9.  Are haemophiliacs protected against cancer development? Prospective controlled studies are needed.

Authors:  Massimo Franchini; Giuseppe Lippi
Journal:  J Cell Mol Med       Date:  2009-02-17       Impact factor: 5.310

10.  First analysis of 10-year trends in national factor concentrates usage in haemophilia: data from CHARMS, the Canadian Hemophilia Assessment and Resource Management System.

Authors:  A N Traore; A K C Chan; K E Webert; N Heddle; B Ritchie; J St-Louis; J Teitel; D Lillicrap; A Iorio; I Walker
Journal:  Haemophilia       Date:  2014-07       Impact factor: 4.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.